This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Baburao Vishnuvajjala: Innovator in Stereoselective Synthesis
Introduction
Baburao Vishnuvajjala is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of chemistry, particularly in the synthesis of nucleosides. His work has implications for various applications in pharmaceuticals and biochemistry.
Latest Patents
Vishnuvajjala holds a patent for "Stereoselective synthesis and process for the manufacturing of 2'-deoxynucleosides." This patent discloses methods for the stereoselective synthesis and manufacturing of 2'-deoxynucleosides, including 2'-ribonucleosides. The patent details the preparation of compounds such as 4'-thio-2'-deoxycytidine (T-dCyd) and 5-aza-4'-thio-2'-deoxycytidine (5-aza-T-dCyd; aza-T-dCyd; aza-T-dC).
Career Highlights
Throughout his career, Baburao Vishnuvajjala has worked with esteemed organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and Alchem Laboratories Corporation. His experience in these institutions has allowed him to develop and refine his innovative techniques in chemical synthesis.
Collaborations
Vishnuvajjala has collaborated with notable colleagues such as Lianhao Zhang and Joel Morris. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Baburao Vishnuvajjala is a distinguished inventor whose work in stereoselective synthesis has paved the way for advancements in the field of nucleosides. His contributions continue to influence research and development in biochemistry and pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
